These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 36694268)
41. Mutations enhance the aggregation propensity of the Alzheimer's A beta peptide. Kim W; Hecht MH J Mol Biol; 2008 Mar; 377(2):565-74. PubMed ID: 18258258 [TBL] [Abstract][Full Text] [Related]
42. Structural dynamics of the ΔE22 (Osaka) familial Alzheimer's disease-linked amyloid β-protein. Inayathullah M; Teplow DB Amyloid; 2011 Sep; 18(3):98-107. PubMed ID: 21668291 [TBL] [Abstract][Full Text] [Related]
43. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Antzutkin ON; Leapman RD; Balbach JJ; Tycko R Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785 [TBL] [Abstract][Full Text] [Related]
44. Toxicity of non-abeta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils. Bodles AM; Guthrie DJ; Harriott P; Campbell P; Irvine GB Eur J Biochem; 2000 Apr; 267(8):2186-94. PubMed ID: 10759841 [TBL] [Abstract][Full Text] [Related]
45. Role of the region 23-28 in Abeta fibril formation: insights from simulations of the monomers and dimers of Alzheimer's peptides Abeta40 and Abeta42. Melquiond A; Dong X; Mousseau N; Derreumaux P Curr Alzheimer Res; 2008 Jun; 5(3):244-50. PubMed ID: 18537541 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component. Janciauskiene S; García de Frutos P; Carlemalm E; Dahlbäck B; Eriksson S J Biol Chem; 1995 Nov; 270(44):26041-4. PubMed ID: 7592799 [TBL] [Abstract][Full Text] [Related]
47. Opposing Effects of Cucurbit[7]uril and 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranose on Amyloid β25-35 Assembly. de Almeida NE; Do TD; Tro M; LaPointe NE; Feinstein SC; Shea JE; Bowers MT ACS Chem Neurosci; 2016 Feb; 7(2):218-26. PubMed ID: 26629788 [TBL] [Abstract][Full Text] [Related]
48. Additive toxicity of β-amyloid by a novel bioactive peptide in vitro: possible implications for Alzheimer's disease. Garcia-Ratés S; Lewis M; Worrall R; Greenfield S PLoS One; 2013; 8(2):e54864. PubMed ID: 23390503 [TBL] [Abstract][Full Text] [Related]
49. Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide Aβ(1-42). Ryan TM; Friedhuber A; Lind M; Howlett GJ; Masters C; Roberts BR J Biol Chem; 2012 May; 287(20):16947-54. PubMed ID: 22461629 [TBL] [Abstract][Full Text] [Related]
50. Alzheimer's beta-amyloid: insights into fibril formation and structure from Congo red binding. Inouye H; Kirschner DA Subcell Biochem; 2005; 38():203-24. PubMed ID: 15709480 [TBL] [Abstract][Full Text] [Related]